A detailed history of Wpg Advisers, LLC transactions in Argenx Se stock. As of the latest transaction made, Wpg Advisers, LLC holds 63 shares of ARGX stock, worth $35,390. This represents 0.03% of its overall portfolio holdings.

Number of Shares
63
Previous 53 18.87%
Holding current value
$35,390
Previous $32.6 Million 14.4%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$571.0 - $671.75 $5,710 - $6,717
10 Added 18.87%
63 $37.3 Million
Q4 2024

May 15, 2025

BUY
$520.52 - $638.33 $27,587 - $33,831
53 New
53 $32.6 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.1B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Wpg Advisers, LLC Portfolio

Follow Wpg Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wpg Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wpg Advisers, LLC with notifications on news.